These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 34341521
1. Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III. Di Lorenzo G, Westermann LM, Yorgan TA, Stürznickel J, Ludwig NF, Ammer LS, Baranowsky A, Ahmadi S, Pourbarkhordariesfandabadi E, Breyer SR, Board TN, Foster A, Mercer J, Tylee K, Velho RV, Schweizer M, Renné T, Braulke T, Randon DN, Sperb-Ludwig F, de Camargo Pinto LL, Moreno CA, Cavalcanti DP, Amling M, Kutsche K, Winter D, Muschol NM, Schwartz IVD, Rolvien T, Danyukova T, Schinke T, Pohl S. Genet Med; 2021 Dec; 23(12):2369-2377. PubMed ID: 34341521 [Abstract] [Full Text] [Related]
7. Molecular analysis of cell lines from patients with mucolipidosis II and mucolipidosis III. Zarghooni M, Dittakavi SS. Am J Med Genet A; 2009 Dec; 149A(12):2753-61. PubMed ID: 19938078 [Abstract] [Full Text] [Related]
11. Identification and characterization of 30 novel pathogenic variations in 69 unrelated Indian patients with Mucolipidosis Type II and Type III. Pasumarthi D, Gupta N, Sheth J, Jain SJMN, Rungsung I, Kabra M, Ranganath P, Aggarwal S, Phadke SR, Girisha KM, Shukla A, Datar C, Verma IC, Puri RD, Bhavsar R, Mistry M, Sankar VH, Gowrishankar K, Agrawal D, Nair M, Danda S, Soni JP, Dalal A. J Hum Genet; 2020 Nov; 65(11):971-984. PubMed ID: 32651481 [Abstract] [Full Text] [Related]
12. GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II through distinct mechanisms. Ludwig NF, Velho RV, Sperb-Ludwig F, Acosta AX, Ribeiro EM, Kim CA, Gandelman Horovitz DD, Boy R, Rodovalho-Doriqui MJ, Lourenço CM, Santos ES, Braulke T, Pohl S, Schwartz IVD. Int J Biochem Cell Biol; 2017 Nov; 92():90-94. PubMed ID: 28918368 [Abstract] [Full Text] [Related]
13. Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene. Cury GK, Matte U, Artigalás O, Alegra T, Velho RV, Sperb F, Burin MG, Ribeiro EM, Lourenço CM, Kim CA, Valadares ER, Galera MF, Acosta AX, Schwartz IV. Gene; 2013 Jul 15; 524(1):59-64. PubMed ID: 23566849 [Abstract] [Full Text] [Related]
14. Dilated cardiomyopathy in mucolipidosis type 2. Carboni E, Sestito S, Lucente M, Morrone A, Zampini L, Chimenz R, Ceravolo MD, De Sarro R, Ceravolo G, Calabrò MP, Parisi F, Moricca MT, Pensabene L, Musolino D, Concolino D. J Biol Regul Homeost Agents; 2020 Jul 15; 34(4 Suppl. 2):71-77. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000604 [Abstract] [Full Text] [Related]
15. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. Kudo M, Brem MS, Canfield WM. Am J Hum Genet; 2006 Mar 15; 78(3):451-63. PubMed ID: 16465621 [Abstract] [Full Text] [Related]
16. Enzyme-specific differences in mannose phosphorylation between GlcNAc-1-phosphotransferase αβ and γ subunit deficient zebrafish support cathepsin proteases as early mediators of mucolipidosis pathology. Flanagan-Steet H, Matheny C, Petrey A, Parker J, Steet R. Biochim Biophys Acta; 2016 Sep 15; 1860(9):1845-53. PubMed ID: 27241848 [Abstract] [Full Text] [Related]
17. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition. Qian Y, van Meel E, Flanagan-Steet H, Yox A, Steet R, Kornfeld S. J Biol Chem; 2015 Jan 30; 290(5):3045-56. PubMed ID: 25505245 [Abstract] [Full Text] [Related]
18. Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB). De Pace R, Coutinho MF, Koch-Nolte F, Haag F, Prata MJ, Alves S, Braulke T, Pohl S. Hum Mutat; 2014 Mar 30; 35(3):368-76. PubMed ID: 24375680 [Abstract] [Full Text] [Related]
19. Combined in vitro and in silico analyses of missense mutations in GNPTAB provide new insights into the molecular bases of mucolipidosis II and III alpha/beta. Danyukova T, Ludwig NF, Velho RV, Harms FL, Güneş N, Tidow H, Schwartz IV, Tüysüz B, Pohl S. Hum Mutat; 2020 Jan 30; 41(1):133-139. PubMed ID: 31579991 [Abstract] [Full Text] [Related]
20. Analyses of disease-related GNPTAB mutations define a novel GlcNAc-1-phosphotransferase interaction domain and an alternative site-1 protease cleavage site. Velho RV, De Pace R, Klünder S, Sperb-Ludwig F, Lourenço CM, Schwartz IV, Braulke T, Pohl S. Hum Mol Genet; 2015 Jun 15; 24(12):3497-505. PubMed ID: 25788519 [Abstract] [Full Text] [Related] Page: [Next] [New Search]